| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.02 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.11 | 0.03 |